What is the relationship between the Learningrx General Release and the renewal franchise agreement?

According to the 2025 Learningrx Franchise Disclosure Document, the General Release (Exhibit G) is executed by the franchisee in connection with entering into a renewal franchise agreement. Specifically, the FDD states that the General Release is made and executed by the franchisee in connection with the franchisee's entry into a renewal franchise agreement for a renewal term pursuant to Section 3 of the franchise agreement. This indicates that as a condition of renewing their franchise agreement, Learningrx requires franchisees to sign a General Release.

The General Release serves to release Learningrx from any and all claims, demands, damages, actions, causes of action, or suits of any kind, both known and unknown, that the franchisee may have against Learningrx through the effective date of the release. This includes, but is not limited to, claims related to breach of contract or defamation. The release applies to all agreements or contracts existing between the franchisee and Learningrx prior to or as of the effective date.

Furthermore, the General Release includes an agreement from the franchisee never to sue Learningrx on any alleged promise, representation, or warranty not expressly set forth in the release. The document also states that it contains the entire agreement between the parties regarding the matters specified and supersedes any prior negotiations or proposed agreements. This means that upon signing the General Release, the franchisee is relinquishing any rights to make claims against Learningrx based on past events or agreements, except as explicitly stated in the release itself.

It is important for prospective Learningrx franchisees to carefully review the terms of the General Release with legal counsel to fully understand the implications of signing such a document, especially in the context of renewing their franchise agreement. Franchisees should be aware that signing the General Release is a condition of renewal and that it releases Learningrx from a broad range of potential liabilities.